After COVID and drug shortages, EU revamps drug laws

Explainer: After COVID and drug shortages, EU revamps drug laws The EU is revamping laws governing the 136 billion euro ($148 billion) pharmaceuticals industry aimed at reviving investment and boosting access to affordable drugs at a time when health budgets have been drained by the costs of treating COVID-19. Maggie Fick Reuters

...

Shortages of critical drugs from antibiotics to painkillers this winter and the COVID pandemic exposed problems caused by declining manufacturing in Europe, complicated supply chains and a lack of preparedness for a global public health emergency.

...